Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
Clinical trial NCT00210600 · COMPLETED
Trial details
- NCT number
- NCT00210600
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.